Suchergebnisse - "Smeijer, J. David"

PubPharm (9)

1

Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney disease

enthalten in: Kidney international | 2023

von Chan, K. | Smeijer, J. | Schechter, M. | +9

CommentIn: Kidney Int. 2023 Dec;104(6):1062-1064. - PMID 37981428

2

Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease

enthalten in: Cardiovascular diabetology | 2023

von Smeijer, J. | Kohan, D. | Rossing, P. | +7

3

Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease

enthalten in: Cardiovascular diabetology | 2023

von Smeijer, J. | Kohan, D. | Rossing, P. | +7

4

Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease

enthalten in: Cardiovascular diabetology | 2023

von Smeijer, J. | Kohan, D. | Rossing, P. | +7

5

Diuretic medication and change in fluid retention biomarkers during treatment with the endothelin receptor antagonist atrasentan

enthalten in: Diabetes, obesity & metabolism | 2023

von Smeijer, J. | Kohan, D. | de Zeeuw, D. | +1

6

Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease

enthalten in: Clinical pharmacology and therapeutics | 2022

von Smeijer, J. | Koomen, J. | Kohan, D. | +14

7

Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure

enthalten in: JACC. Heart failure | 2022

von Smeijer, J. | Koomen, J. | Kohan, D. | +13

CommentIn: JACC Heart Fail. 2022 Jul;10(7):508-511. - PMID 35772862

8

Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long‐Term Response to Atrasentan in Patients With Diabetic Kidney Disease

enthalten in: Clinical Pharmacology & Therapeutics | 2022

von Smeijer, J. | Koomen, J. | Kohan, D. | +14

9

Endothelin receptor antagonists for the treatment of diabetic and nondiabetic chronic kidney disease

enthalten in: Current opinion in nephrology and hypertension | 2021

von Smeijer, J. | Kohan, D. | Webb, D. | +2

1
[1]